Company registration number 04746712 (England and Wales)
ABBEY TOTAL CARE GROUP LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2026
ABBEY TOTAL CARE GROUP LIMITED
COMPANY INFORMATION
Directors
Mr J Patel
Mrs D Patel
Secretary
Mrs D Patel
Company number
04746712
Registered office
9 Spareleaze Hill
Loughton
Essex
IG10 1BS
Auditor
Alwyns LLP
Crown House
151 High Road
Loughton
Essex
IG10 4LG
Business address
Accounts Office, Abbey Care Complex
27-29 Abbey Road
Newbury Park
Ilford
Essex
IG2 7NE
ABBEY TOTAL CARE GROUP LIMITED
CONTENTS
Page
Strategic report
1 - 5
Directors' report
6 - 8
Independent auditor's report
9 - 11
Profit and loss account
12
Group statement of comprehensive income
13
Group balance sheet
14
Company balance sheet
15
Group statement of changes in equity
16
Company statement of changes in equity
17
Group statement of cash flows
18
Notes to the financial statements
19 - 35
ABBEY TOTAL CARE GROUP LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 30 APRIL 2026
- 1 -

The directors present the Annual Report for the year ended 30 April 2026.

The principal activities of the Group continue to be the ownership and operation of care homes, providing accommodation, nursing care, dementia care, rehabilitation and specialist support services for older people and individuals with complex healthcare needs.

The Group owns and operates 11 care homes comprising 645 registered beds within Greater London. Through continued investment in its facilities, services and infrastructure, the Group remains committed to delivering high-quality, person-centred care whilst pursuing sustainable long-term growth.

The Group delivered a strong financial and operational performance during the year despite continued challenges affecting the health and social care sector.

Turnover increased to £49.4m (2025: £42.4m), reflecting improved operational performance, sustained demand for the Group's services and the full-year contribution from Ashbrook Nursing Home acquired on 30 April 2025. Operating profit increased to £13.6m (2025: £10.8m), whilst profit before taxation increased to £11.3m (2025: £8.5m).

Strong cash generation throughout the year supported continued investment across the Group's property portfolio and strategic development programme. Total equity increased to £75.2m (2025: £66.8m), further strengthening the Group's financial position and providing a robust platform to support future growth opportunities.

Whilst the operating environment continued to be influenced by inflationary pressures, workforce shortages and funding constraints within Local Authority and NHS commissioning arrangements, the Group maintained strong profitability through disciplined financial management, operational efficiency and a continued focus on service quality.

Occupancy levels were temporarily affected during the year by redevelopment activities, regulatory capacity restrictions and certain operational factors. Occupancy has strengthened following the year end and remains a key focus of management as redevelopment projects reach completion and additional capacity becomes available.

The Group continues to benefit from an experienced management team, established governance structures and a resilient operating model. This has enabled the business to navigate challenging market conditions whilst continuing to invest in future growth and service development.

The Group's long-term strategy remains focused on operational excellence, selective expansion and the development of complementary healthcare and wellbeing services.

A significant milestone has been achieved at Forest Place, where the second phase of the redevelopment project is approaching completion. Upon completion, the scheme will provide 165 high-quality care units, including 45 extra-care assisted living apartments together with a range of supporting healthcare and wellbeing facilities.

During the year, the Group also acquired an additional development site within the RM5 postcode area, providing an opportunity to further expand its healthcare offering and support future growth. The Directors continue to evaluate opportunities across the portfolio, including the expansion of existing facilities, redevelopment projects and strategic acquisitions where these align with the Group's long-term objectives.

Planning consent has already been secured for future expansion at it’s Ravenscroft care home and additional opportunities continue to be assessed at it’s Balham care home and other strategically important locations.

An important component of the Group's future strategy is the proposed Forest Palace Medical and Wellbeing Centre, which is intended to complement existing care services through the provision of integrated healthcare, rehabilitation and wellbeing facilities. The project reflects the Group's broader objective of investing in infrastructure that supports changing healthcare needs whilst enhancing service provision for both residents and the wider community.

ABBEY TOTAL CARE GROUP LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 2 -

The Group believes that demand for integrated care, rehabilitation, preventative healthcare and wellbeing services will continue to increase in the coming years. Its development strategy is therefore designed to position the business to respond to evolving healthcare requirements whilst creating sustainable long-term value for service users, employees, commissioners and shareholders.

The continued success of the Group depends upon the commitment, professionalism and expertise of its workforce.

Average employee numbers increased to 842 (2025: 745), reflecting continued growth across the portfolio. The Group remains committed to attracting, developing and retaining skilled employees through training, professional development and leadership programmes that support both service quality and career progression.

The Group also continues to draw upon specialist expertise in areas including clinical governance, quality assurance, regulatory compliance and operational support, helping to ensure consistently high standards across all services.

The Group operates within a highly regulated environment and maintains robust systems of governance, quality assurance and regulatory oversight. These arrangements support compliance with Care Quality Commission requirements, safeguarding obligations, health and safety legislation and other applicable regulatory standards.

Investment continues to be made in care management systems, digital technologies and data-driven processes that support improved resident outcomes, stronger clinical governance and enhanced operational efficiency.

The Group maintains constructive relationships with residents, relatives, Local Authorities, NHS organisations, Integrated Care Boards, General Practitioners and other healthcare partners. These relationships remain fundamental to the delivery of safe, effective and person-centred care.

The Board recognises that environmental, social and governance ("ESG") considerations form an important part of the Group's long-term sustainability and responsible business practices.

The Group seeks to reduce its environmental impact through responsible energy management, investment in more efficient infrastructure, building modernisation programmes, waste reduction initiatives and sustainable procurement practices. Environmental considerations are incorporated into development and refurbishment projects where appropriate.

The Group's primary social purpose remains the delivery of high-quality care that improves lives and supports communities. Through its services, the Group provides care, employment and training opportunities across diverse communities whilst maintaining strong relationships with residents, families, healthcare professionals, suppliers and commissioning authorities.

The proposed Forest Palace Medical and Wellbeing Centre further reflects the Group's commitment to supporting community wellbeing through improved access to rehabilitation, preventative healthcare and integrated health services.

Strong governance underpins all aspects of the Group's activities. The Board maintains oversight of strategy, financial performance, risk management, safeguarding, regulatory compliance and clinical governance, supporting effective decision-making and accountability throughout the organisation.

Principal risks

The Group operates within a highly regulated and increasingly challenging environment and is exposed to a range of strategic, operational, financial and regulatory risks. These include inflationary pressures on operating costs, workforce recruitment and retention challenges, regulatory and legislative developments, and ongoing constraints within Local Authority and NHS funding arrangements.

The Group is also affected by broader economic conditions, including occupancy fluctuations, increases in utility and insurance costs, interest rate movements and risks associated with development and capital investment projects. Such factors have the potential to influence both short-term financial performance and the delivery of the Group's long-term strategic objectives.

The Board maintains a comprehensive framework for identifying, assessing and managing principal risks and uncertainties and regularly reviews the effectiveness of internal controls and risk mitigation measures. The Group's strong balance sheet, substantial property asset base, healthy liquidity position and diversified revenue streams provide a significant degree of resilience and support the continued delivery of its long-term strategy.

ABBEY TOTAL CARE GROUP LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 3 -
Key performance indicators

The Group's key performance indicators ("KPIs") are reviewed regularly by the Board and senior management team as part of the ongoing assessment of operational and financial performance. Detailed monthly management accounts and performance reports are prepared and reviewed throughout the year.

KPI

2025/26

2024/25

 

Revenue

£49.4m

£42.4m

Revenue improved due to operational performance and the full-year contribution from Ashbrook Nursing Home acquired on 30 April 2025

Operating Profit

£13.6m

£10.8m

Increase in Operating Profit is driven by revenue growth, the full-year contribution from Ashbrook Nursing Home and ongoing operational efficiencies.

 

Occupancy Rate

90%

91%

Occupancy reduced marginally during the year, primarily as a result of redevelopment activities, regulatory capacity restrictions and temporary operational factors. Occupancy levels have strengthened since the year end and remain an important indicator of operational performance and future growth.

Registered Beds

645

645

Registered capacity is expected to increase to 690 beds following the registration of an additional 45 care units arising from the completion of Forest Place Phase 2.

Future Outlook

The Directors remain confident in the Group's long-term prospects and believe that the business is well positioned to benefit from opportunities arising across the health, wellbeing and care sectors.

Supported by a strong balance sheet, substantial property assets, healthy liquidity and an experienced management team, the Group has a solid platform from which to pursue its strategic objectives. Key elements of the Group's growth strategy include the completion and operational ramp-up of the Forest Place development, the progression of expansion opportunities at Ravenscroft and Balham, the longer-term development of the recently acquired RM5 site and the continued evaluation of selective acquisition opportunities.

The proposed Forest Palace Medical and Wellbeing Centre is expected to play an important role in broadening the Group's healthcare offering and supporting the delivery of integrated care, rehabilitation and preventative health services. Together with ongoing investment in healthcare, pharmacy, wellbeing and community-based services, these initiatives are intended to support the Group's long-term growth ambitions and enhance the range of services available to residents, patients and local communities.

Whilst recognising the challenges inherent within an evolving and highly regulated sector, including economic conditions, workforce availability, regulatory developments and commissioning arrangements, the Directors remain confident in the Group's ability to deliver sustainable long-term growth whilst maintaining its commitment to high-quality care and positive outcomes for residents, patients, families and communities.

ABBEY TOTAL CARE GROUP LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 4 -
S172 statement

The directors of the Company, as those of all UK companies, must act in accordance with a set of general duties. These duties are detailed in section 172 of the UK Companies Act 2006 which is summarised as follows:

 

‘A director of a company must act in the way they consider, in good faith, would be most likely to promote the success of the company for the benefit of its shareholders as a whole and, in doing so have regard (amongst other matters) to:

 

•    the likely consequences of any decisions in the long term;

 

•    the interests of the company’s employees;

 

•    the need to foster the company’s business relationships with suppliers, customers and others;

 

•    the impact of the company’s operations on the community and environment;

 

•    the desirability of the company maintaining a reputation for high standards of business conduct; and

 

•    the need to act fairly as between members of the Company.

 

Risk Management

As we grow, our business and our risk environment also become more complex. It is therefore vital that we effectively identify, evaluate, manage and mitigate the risks we face, and that we continue to evolve our approach. We have set out earlier in this report our principle risks and how we manage our risk environment.

 

Our people

The group remains firmly committed to conducting its business responsibly and sustainably. Our actions and decisions are guided by the expectations of our people, service users, investors, communities, and wider society. Continued success depends on effectively managing performance, developing and retaining talent, and maintaining operational efficiency. We also place strong emphasis on shared values that underpin our culture and guide our conduct, ensuring that our objectives are achieved in a responsible and ethical manner.

Business Relationships

Our strategy priorities organic growth. To do this, we need to develop and maintain strong customer relationships. We value all of our suppliers.

 

Community and Environment

The Group’s approach is to use our position of strength to create positive change for the people and communities with which we interact.

 

Reputation maintenance

The board expects the highest standards of business conduct. The directors receive updates in respect of matters of regulatory compliance and further escalated issues.

 

Shareholders

The board contains all the company’s shareholders so there is never a conflict between the two parties.

ABBEY TOTAL CARE GROUP LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 5 -

The directors take this opportunity to thank all the stakeholders, frontline staff and management, the suppliers, the commissioning and contracting authorities, the social and healthcare workers for their continued invaluable support in the operation of the business. The directors extend our thanks to all the families and relatives for their understanding and working in partnership with the group.

On behalf of the board

Mr J Patel
Director
28 October 2026
ABBEY TOTAL CARE GROUP LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 APRIL 2026
- 6 -

The directors present their financial statements for the year ended 30 April 2026.

 

Results and dividends

The results for the year are set out on page 12.

Ordinary dividends were paid amounting to £85,000. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr J Patel
Mrs D Patel
Political donations

The group made the following political donations in the current year:

 

Epping Forest Conservatives - £2,750

Financial instruments
Treasury operations and financial instruments

The group's principal financial instruments are credit facilities and loans, the main purpose of which is to finance the group's operations. In addition, the group has various other financial assets and liabilities such as trade debtors and trade creditors arising directly from operations.

Liquidity risk

Liquidity risk is addressed by holding adequate liquid assets and through appropriate controls. The group continually reviews the residual risks arising and has mitigating actions in place to reduce the levels of these risks. Added to the liquid assets, a portion of the bank facility always remains undrawn to overcome unforeseen eventualities.

Interest rate risk

The group is exposed to interest rate risk on its bank and loan note. The group has agreed favourable interest rates on group cash credit balances which will help to offset the interest rate risk on borrowing.

Credit risk

Investments of cash surpluses and borrowings are made through banks which must fulfil credit rating criteria approved by the Board. All service users enter into formal agreements with the group which stipulate payment terms. The directors regularly review trade debtors and pursue any outstanding debts on a timely basis. Where necessary, provisions are made for doubtful debts.

ABBEY TOTAL CARE GROUP LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 7 -
Employee involvement

Abbey Total Care Group Limited has continued its development of an in-house learning facility. The group ensures that all care employees are trained up to the industry standard (appropriate QCF levels). This learning facility provides in-house trainers and assessors to deliver appropriate instructions and evaluation. Our trainers are experts familiar with the company’s values, policies and procedures. These training sessions have been welcomed by employees for their the more interactive style and content.

 

The group's policy remains that of a positive approach to problem solving and improving efficiency through consultations and discussions with employees at staff councils and meetings, for matters likely to affect employees' interests. All matters of concern by individuals are resolved as they arise by the manager.

 

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the group's performance.

Future developments

The Group is very pleased with the improving performance in health provision and aged care. We are doing everything we can to offer support to people in need. Our teams continue enthusiastically to deliver high standards of service for our customers at the same time as we transform the business.

 

The group continues to go from strength to strength, building on its solid foundation and years of expertise in the business. It has grown over the years by making progressive changes to existing buildings, conversions and new-builds. Importance is always given to developments that are superior and can provide a level of customer satisfaction which is exceptional. ‘Value for money and helping people live longer, healthier, happier lives’ are the key principles on which the Group’s foundations lie. We believe Abbey Total Care Group has an increasing part to play in the health of its customers.

 

Our ‘Care First’ approach will always be at the forefront all our activities. This approach has resulted in continuous training and development initiatives for all employees.

 

Forest Place, the group’s flagship home in Buckhurst Hill, located within the prestigious Epping Forest District of Essex, in the final stages of its Phase two development to supply additional beds, assisted living units for customers, restaurant facilities and an extensive medical centre.

 

Future planning includes new smaller developments at many of the group's other homes, to be rolled out soon after execution of the above project.

Auditor

The auditor, Alwyns LLP is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Energy and carbon report

Whilst the overall group has consumed more than 40,000 kWh of energy in this reporting period, none of the individual subsidiaries are large as defined by the Companies Act. In preparing this group Director’s Report, we have taken advantage of the option to exclude any energy and carbon information relating to those subsidiaries.

 

As the parent entity has very limited energy consumption, there is no energy and carbon information to be reported in respect of the parent entity.

ABBEY TOTAL CARE GROUP LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 8 -
Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law, the directors have prepared the group and parent company financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and parent company, and of the profit or loss of the group for that period.

 

In preparing these financial statements, the directors are required to:

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and parent company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and parent company, and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and parent company, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

On behalf of the board
Mr J Patel
Director
28 October 2026
ABBEY TOTAL CARE GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF ABBEY TOTAL CARE GROUP LIMITED
- 9 -
Opinion

We have audited the financial statements of Abbey Total Care Group Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 30 April 2026 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

ABBEY TOTAL CARE GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF ABBEY TOTAL CARE GROUP LIMITED
- 10 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the group's and parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Audit procedures undertaken in responses to the potential risks relating to irregularities (which include fraud and non-compliance with laws and regulations) comprised of: enquiries of management and those charged with governance as to whether the entity complies with such laws and regulations; enquiries with the same concerning any actual or potential litigation or claim; inspection of relevant legal correspondence; review of published Care Quality Commission (CQC) inspection reports, inspection of health and safety reports, inspection of Food Standards Agency certificates, testing the appropriateness of entries in the nominal ledger, including journal entries; reviewing transactions around the end of the reporting period; and the performance of analytical procedures to identify unexpected movements in account balances which may be indicative of fraud.

 

No instances of material non-compliance were identified. However, the likelihood of detecting irregularities, including fraud, is limited by the inherent difficulty in detecting irregularities, the effectiveness of the entity's controls, and the nature, timing and extent of the audit procedures performed. Irregularities that result from fraud might be inherently more difficult to detect than irregularities that result from error. As stated above, there is an unavoidable risk that material misstatements my not be detected, even though the audit have been planned and performed in accordance with ISAs (UK).

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

ABBEY TOTAL CARE GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF ABBEY TOTAL CARE GROUP LIMITED
- 11 -

Use of our report

This report is made solely to the parent company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

David Stanley (Senior Statutory Auditor)
For and on behalf of Alwyns LLP
28 October 2026
Chartered Accountants
Statutory Auditor
Crown House
151 High Road
Loughton
Essex
IG10 4LG
ABBEY TOTAL CARE GROUP LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 30 APRIL 2026
- 12 -
2026
2025
Notes
£
£
Turnover
3
49,398,789
42,395,069
Cost of sales
(28,880,998)
(24,773,960)
Gross profit
20,517,791
17,621,109
Administrative expenses
(7,394,078)
(7,124,257)
Other operating income
432,672
312,257
Operating profit
4
13,556,385
10,809,109
Interest receivable and similar income
8
253,385
431,835
Interest payable and similar expenses
9
(2,259,678)
(2,081,929)
Fair value gains/(losses) on financial instruments
10
(216,124)
(700,069)
Profit before taxation
11,333,968
8,458,946
Tax on profit
11
(2,837,173)
(2,095,692)
Profit for the financial year
8,496,795
6,363,254
Profit for the financial year is attributable to:
- Owners of the parent company
8,483,513
6,256,286
- Non-controlling interests
13,282
106,968
8,496,795
6,363,254

The profit and loss account has been prepared on the basis that all operations are continuing operations.

ABBEY TOTAL CARE GROUP LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 APRIL 2026
- 13 -
2026
2025
£
£
Profit for the year
8,496,795
6,363,254
Other comprehensive income net of taxation
-
-
Total comprehensive income for the year
8,496,795
6,363,254
Total comprehensive income for the year is attributable to:
- Owners of the parent company
8,483,513
6,256,286
- Non-controlling interests
13,282
106,968
8,496,795
6,363,254
ABBEY TOTAL CARE GROUP LIMITED
GROUP BALANCE SHEET
AS AT 30 APRIL 2026
30 April 2026
- 14 -
2026
2025
Notes
£
£
£
£
Fixed assets
Goodwill
13
(3,418,597)
(4,296,223)
Total intangible assets
(3,418,597)
(4,296,223)
Tangible assets
14
124,214,063
121,193,609
120,795,466
116,897,386
Current assets
Debtors
17
5,594,954
6,391,953
Cash at bank and in hand
7,826,813
7,254,144
13,421,767
13,646,097
Creditors: amounts falling due within one year
18
(13,569,088)
(12,953,528)
Net current (liabilities)/assets
(147,321)
692,569
Total assets less current liabilities
120,648,145
117,589,955
Creditors: amounts falling due after more than one year
19
(33,773,238)
(39,341,104)
Provisions for liabilities
Deferred tax liability
23
11,674,416
11,460,155
(11,674,416)
(11,460,155)
Net assets
75,200,491
66,788,696
Capital and reserves
Called up share capital
25
321
321
Revaluation reserve
32,250,932
32,250,932
Other reserves
(299,951)
(299,951)
Profit and loss reserves
42,295,574
33,897,061
Equity attributable to owners of the parent company
74,246,876
65,848,363
Non-controlling interests
953,615
940,333
Total equity
75,200,491
66,788,696
The financial statements were approved by the board of directors and authorised for issue on 28 October 2026 and are signed on its behalf by:
28 October 2026
Mr J Patel
Director
Company registration number 04746712 (England and Wales)
ABBEY TOTAL CARE GROUP LIMITED
COMPANY BALANCE SHEET
AS AT 30 APRIL 2026
30 April 2026
- 15 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
14
177,346
205,497
Investments
15
13,733,115
13,733,015
13,910,461
13,938,512
Current assets
Debtors
17
45,858,187
40,204,449
Cash at bank and in hand
5,730,104
5,000,005
51,588,291
45,204,454
Creditors: amounts falling due within one year
18
(6,117,204)
(5,929,243)
Net current assets
45,471,087
39,275,211
Total assets less current liabilities
59,381,548
53,213,723
Creditors: amounts falling due after more than one year
19
(33,773,238)
(39,341,104)
Provisions for liabilities
23
-
0
(28,443)
Net assets
25,608,310
13,844,176
Capital and reserves
Called up share capital
25
321
321
Profit and loss reserves
25,607,989
13,843,855
Total equity
25,608,310
13,844,176

As permitted by section 408 of the Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £11,849,134 (2025 - £12,022,960 profit).

The financial statements were approved by the board of directors and authorised for issue on 28 October 2026 and are signed on its behalf by:
28 October 2026
Mr J Patel
Director
Company Registration No. 04746712
ABBEY TOTAL CARE GROUP LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2026
- 16 -
Share capital
Revaluation reserve
Other reserves
Profit and loss reserves
Total controlling interest
Non-controlling interest
Total
Notes
£
£
£
£
£
£
£
Balance at 1 May 2024
321
32,165,189
(357,491)
27,640,775
59,448,794
1,052,648
60,501,442
Year ended 30 April 2025:
Profit and total comprehensive income
-
-
-
6,256,286
6,256,286
106,968
6,363,254
Purchase of shares in subsidiary from non-controlling interest
-
-
-
-
-
(219,283)
(219,283)
Other movements
-
85,743
57,540
-
143,283
-
143,283
Balance at 30 April 2025
321
32,250,932
(299,951)
33,897,061
65,848,363
940,333
66,788,696
Year ended 30 April 2026:
Profit and total comprehensive income
-
-
-
8,483,513
8,483,513
13,282
8,496,795
Dividends
12
-
-
-
(85,000)
(85,000)
-
(85,000)
Balance at 30 April 2026
321
32,250,932
(299,951)
42,295,574
74,246,876
953,615
75,200,491
ABBEY TOTAL CARE GROUP LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 APRIL 2026
- 17 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 May 2024
321
1,820,895
1,821,216
Year ended 30 April 2025:
Profit and total comprehensive income
-
12,022,960
12,022,960
Balance at 30 April 2025
321
13,843,855
13,844,176
Year ended 30 April 2026:
Profit and total comprehensive income
-
11,849,134
11,849,134
Dividends
12
-
(85,000)
(85,000)
Balance at 30 April 2026
321
25,607,989
25,608,310
ABBEY TOTAL CARE GROUP LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 APRIL 2026
- 18 -
2026
2025
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
28
13,692,689
10,589,525
Interest paid
(1,996,660)
(2,035,447)
Income taxes paid
(2,648,225)
(1,122,538)
Net cash inflow from operating activities
9,047,804
7,431,540
Investing activities
Purchase of subsidiary undertakings
-
(4,577,741)
Purchase of tangible fixed assets
(2,294,131)
(1,832,192)
Interest received
253,385
431,835
Net cash used in investing activities
(2,040,746)
(5,978,098)
Financing activities
Repayment of loan notes
(1,200,000)
-
0
Repayment of bank loans
(4,537,580)
(2,280,000)
Payment of finance leases obligations
(35,692)
(35,693)
Dividends paid to equity shareholders
(85,000)
-
Net cash used in financing activities
(5,858,272)
(2,315,693)
Net increase/(decrease) in cash and cash equivalents
1,148,786
(862,251)
Cash and cash equivalents at beginning of year
6,572,990
7,435,241
Cash and cash equivalents at end of year
7,721,776
6,572,990
Relating to:
Cash at bank and in hand
7,826,813
7,254,144
Bank overdrafts included in creditors payable within one year
(105,037)
(681,154)
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2026
- 19 -
1
Accounting policies
Company information

Abbey Total Care Group Limited ("the company") is a private company limited by shares incorporated in England and Wales. The registered office is 9 Spareleaze Hill, Loughton, Essex, IG10 1BS.

The group consists of Abbey Total Care Group Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest whole pound.

The financial statements have been prepared on the historical cost convention, modified to include the revaluation of freehold properties and derivative financial instruments. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group that prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

 

1.2
Basis of consolidation

The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination and includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date.

The consolidated financial statements incorporate those of Abbey Total Care Group Limited and all of its subsidiaries (ie entities that the group controls through its power to govern the financial and operating policies so as to obtain economic benefits). Subsidiaries acquired during the year are consolidated using the purchase method. Their results are incorporated from the date that control passes.

 

All financial statements are made up to 30 April 2026 and have consistent accounting policies.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
1
Accounting policies
(Continued)
- 20 -
1.3
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company and its subsidiary undertakings have adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

1.5
Intangible fixed assets - goodwill

Goodwill represents the difference between the fair value of the consideration paid on the acquisition of a business and the fair value of the separable net assets. Goodwill is capitalised and amortised in equal annual instalments over its estimated useful economic life. Apart from negative goodwill attributable to fixed assets which is amortised over the shorter of expected life of the assets or 50 years. The balance sheet carrying value of goodwill is reviewed for impairment at the end of the first full financial year following acquisition and in other periods if events or changes in circumstances indicate that the carrying value may not be recovered.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Land and buildings are not depreciated. The buildings are continually maintained, therefore the residual value is such that the depreciation on buildings is nil.

 

Apart from land and buildings, depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures, fittings & equipment
10-25% reducing balance
Motor vehicles
25% reducing balance
Equipment (short life)
over a period of 3 years

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

1.7
Fixed asset investments

In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.8
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately through the profit and loss account, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
1
Accounting policies
(Continued)
- 21 -
1.9
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities and bank overdrafts.

1.10
Financial instruments

The group and parent company have elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of their financial instruments.

 

Financial instruments are recognised in the balance sheet when the entity becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including interest rate caps, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
1
Accounting policies
(Continued)
- 22 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loan stock and loans from fellow group and related companies that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value though profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.11
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.12
Taxation
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
1
Accounting policies
(Continued)
- 23 -
1.14
Retirement benefits

The group operates a defined contribution scheme for the benefit of its employees. Contributions payable are charged to the profit and loss account in the period to which they relate.

1.15
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.16

Liquid resources

Liquid resources for the purpose of preparing the cashflow statement includes cash at bank and in hand.

2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements and estimation uncertainty

The following judgements and estimates have had the most significant effect on amounts recognised in the financial statements.

Tangible fixed assets (note 14)

Freehold land and buildings are reflected at fair value based upon a valuation from qualified surveyors. Calculation of the valuation requires judgements to be made and estimates based on information at the time of the valuation including the competitive and economic environment.

Trade debtors (note 17)

At each reporting date the company assesses whether there is any indication of the non recovery of trade debts. If any such indication exists a provision is recognised based on the director's estimate of amounts recoverable.

3
Turnover and other revenue

The group's turnover is generated from its principal activity of the operation of care homes which is wholly undertaken in the United Kingdom.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 24 -
4
Operating profit
2026
2025
£
£
Operating profit for the year is stated after charging/(crediting):
Depreciation of tangible fixed assets
538,859
436,570
Amortisation of intangible assets
(877,626)
(45,953)
5
Auditor's remuneration
2026
2025
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
49,031
24,279
Audit of the financial statements of the company's subsidiaries
29,898
28,907
78,929
53,186
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2026
2025
2026
2025
Number
Number
Number
Number
Resident welfare
780
697
-
7
Administration
62
48
11
3
842
745
11
10

Their aggregate remuneration comprised:

Group
Company
2026
2025
2026
2025
£
£
£
£
Wages and salaries
25,011,871
20,706,732
1,442,805
1,175,367
Social security costs
2,822,948
1,968,502
195,972
152,074
Pension costs
403,987
349,306
6,241
5,801
28,238,806
23,024,540
1,645,018
1,333,242
7
Directors' remuneration
2026
2025
£
£
Remuneration for qualifying services
682,995
400,581
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
7
Directors' remuneration
(Continued)
- 25 -
Remuneration disclosed above includes the following amounts paid to the highest paid director:
2026
2025
£
£
Remuneration for qualifying services
352,123
207,571

Only the directors are considered to be the key management.

8
Interest receivable and similar income
2026
2025
£
£
Interest income
Interest on bank deposits
253,385
420,089
Other interest income
-
11,746
Total income
253,385
431,835
9
Interest payable and similar expenses
2026
2025
£
£
Interest on bank overdrafts and loans
1,905,892
2,007,608
Other interest on financial liabilities
216,536
-
Interest on finance leases and hire purchase contracts
2,276
2,276
Other finance costs
134,974
72,045
Total finance costs
2,259,678
2,081,929
10
Fair value gains/(losses) on financial instruments
2026
2025
£
£
Fair value gains/(losses) on financial instruments
Loss on financial assets held at fair value through profit or loss
(216,124)
(700,069)
11
Taxation
2026
2025
£
£
Current tax
UK corporation tax on profits for the current period
2,622,912
2,067,582
Deferred tax
Origination and reversal of timing differences
214,261
28,110
Total tax charge
2,837,173
2,095,692
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
11
Taxation
(Continued)
- 26 -

The charge for the year can be reconciled to the profit per the profit and loss account as follows:

2026
2025
£
£
Profit before taxation
11,333,968
8,458,946
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2025: 25.00%)
2,833,492
2,114,737
Timing differences of capital allowances against depreciation and deferred taxation
(16,469)
(26,887)
Other tax adjustments
20,150
7,842
Taxation charge
2,837,173
2,095,692
12
Dividends
2026
2025
Recognised as distributions to equity holders:
£
£
Interim paid
85,000
-
13
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 May 2025 and 30 April 2026
(4,681,713)
Amortisation and impairment
At 1 May 2025
(385,490)
Amortisation charged for the year
(877,626)
At 30 April 2026
(1,263,116)
Carrying amount
At 30 April 2026
(3,418,597)
At 30 April 2025
(4,296,223)
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 27 -
14
Tangible fixed assets
Group
Freehold land and buildings
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
Cost or valuation
At 1 May 2025
115,299,626
13,882,431
249,090
129,431,147
Additions
2,309,308
1,250,005
-
0
3,559,313
At 30 April 2026
117,608,934
15,132,436
249,090
132,990,460
Depreciation and impairment
At 1 May 2025
-
0
8,164,239
73,299
8,237,538
Depreciation charged in the year
-
0
494,911
43,948
538,859
At 30 April 2026
-
0
8,659,150
117,247
8,776,397
Carrying amount
At 30 April 2026
117,608,934
6,473,286
131,843
124,214,063
At 30 April 2025
115,299,626
5,718,192
175,791
121,193,609
Company
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
Cost or valuation
At 1 May 2025
363,007
167,542
530,549
Additions
30,964
-
0
30,964
At 30 April 2026
393,971
167,542
561,513
Depreciation and impairment
At 1 May 2025
251,753
73,299
325,052
Depreciation charged in the year
35,554
23,561
59,115
At 30 April 2026
287,307
96,860
384,167
Carrying amount
At 30 April 2026
106,664
70,682
177,346
At 30 April 2025
111,254
94,243
205,497

 

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
14
Tangible fixed assets
(Continued)
- 28 -

Land and buildings held at 30 April 2023 were revalued during the year to 30 April 2023 based on a valuation concluded on 24 May 2023 by Knight Frank LLP, independent valuers not connected with the company, on the basis of market value as defined in the publication RICS Valuation - Global Standards, which incorporate the International Valuation Standards and the RICS UK National Supplement.

 

The directors do not believe there has been any significant change to the values as at 30 April 2026.

 

There has been no depreciation applied on revalued buildings as the residual value is materially the same as the net book value.

If freehold land and buildings were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

2026
2025
£
£
Group
Cost
63,970,492
60,764,036
15
Fixed asset investments
Group
Company
2026
2025
2026
2025
Notes
£
£
£
£
Investments in subsidiaries
16
-
0
-
0
13,733,115
13,733,015

During the year the company subscribed in the shares of a newly formed company, Abbey Staff Agency Limited representing 100% of the issued capital.

Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 May 2025
13,733,015
Additions
100
At 30 April 2026
13,733,115
Carrying amount
At 30 April 2026
13,733,115
At 30 April 2025
13,733,015
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 29 -
16
Subsidiaries

Details of the company's subsidiaries at 30 April 2026 are as follows:

Name of undertaking
Class of
% Held
shares held
Direct
Abbey Care Centre Limited
Ordinary
100.00
Abbey Care Complex Limited
Ordinary
100.00
Abbey Care Services Limited
Ordinary
100.00
Abbey Cheam Centre Limited (Dormant)
Ordinary
100.00
Abbey Ravenscroft Park Limited
Ordinary
100.00
Martlane Limited
Ordinary
95.00
Moreland House Care Home Limited
Ordinary
100.00
Parkside Nursing Home Limited
Ordinary
100.00
Planshore Limited
Ordinary
100.00
Ryedowns Limited
Ordinary
99.90
Woodlands Total Care Nursing Home Limited
Ordinary
100.00
Abbey Uplands Care Home Limited
Ordinary
100.00
Abbey Total Community Care Limited (Dormant)
Ordinary
100.00
Devi (London) Properties Limited (Dormant)
Ordinary
100.00
Newvalley Developments Limited (Dormant)
Ordinary
100.00
Onetree Estates Limited
Ordinary
100.00
Abbey Staff Agency limited
Ordinary
100.00

On 7 November 2025 Abbey Kingston Care Home Limited was renamed to Abbey Total Community Care Limited.

 

The principal activity of the above undertakings, apart from those identified as dormant, was the operation of care homes and ancillary services. All the above companies are registered in the United Kingdom with the same registered office as the parent undertaking.

 

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 30 -
17
Debtors
Group
Company
2026
2025
2026
2025
Amounts falling due within one year:
£
£
£
£
Trade debtors
3,675,590
3,212,511
8,137
7,637
Corporation tax recoverable
344,801
248,303
54,631
54,597
Amounts owed by group undertakings
-
0
-
0
45,469,185
39,168,480
Other debtors
351,559
1,288,774
303,699
757,611
Prepayments and accrued income
1,223,004
1,426,241
22,535
-
0
5,594,954
6,175,829
45,858,187
39,988,325
Measured at fair value through profit and loss:
Derivative financial instruments
-
0
216,124
-
0
216,124
Total debtors
5,594,954
6,391,953
45,858,187
40,204,449
18
Creditors: amounts falling due within one year
Group
Company
2026
2025
2026
2025
Notes
£
£
£
£
Loan notes
20
1,200,000
1,200,000
1,200,000
1,200,000
Bank loans and overdrafts
22
2,083,555
2,809,672
2,083,555
2,809,672
Obligations under finance leases
21
26,769
35,692
26,769
35,692
Trade creditors
4,059,602
3,520,399
164,880
81,311
Amounts owed to group undertakings
-
0
-
0
2,213,204
1,304,019
Corporation tax payable
1,314,002
1,242,817
-
0
-
0
Other taxation and social security
1,298,244
1,827,407
117,011
346,242
Other creditors
1,831,279
2,056,034
67,631
58,059
Accruals and deferred income
1,755,637
261,507
244,154
94,248
13,569,088
12,953,528
6,117,204
5,929,243
19
Creditors: amounts falling due after more than one year
Group
Company
2026
2025
2026
2025
Notes
£
£
£
£
Loan notes
20
3,600,000
4,800,000
3,600,000
4,800,000
Bank loans and overdrafts
22
30,173,238
34,514,335
30,173,238
34,514,335
Obligations under finance leases
21
-
0
26,769
-
0
26,769
33,773,238
39,341,104
33,773,238
39,341,104
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 31 -
20
Loan notes
Group
Company
2026
2025
2026
2025
£
£
£
£
Loan notes
4,800,000
6,000,000
4,800,000
6,000,000

The loan notes were issued on 30 April 2025 as part of the consideration for the acquisition of Onetree Estates Limited. The loan notes are unsecured with interest payable at Bank of England base rate. The loan notes are payable by five equal annual instalments of £1,200,000 but can be redeemed earlier on the agreement of the company.

21
Finance lease obligations
Group
Company
2026
2025
2026
2025
Amounts due:
£
£
£
£
Current liabilities
26,769
35,692
26,769
35,692
Non-current liabilities due within five years
-
0
26,769
-
0
26,769
26,769
62,461
26,769
62,461

Finance lease payments represent rentals payable by the company for certain items of plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 5 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.

22
Bank loans and overdrafts
Group
Company
2026
2025
2026
2025
£
£
£
£
Bank loans
32,151,756
36,642,853
32,151,756
36,642,853
Bank overdrafts
105,037
681,154
105,037
681,154
32,256,793
37,324,007
32,256,793
37,324,007
Payable within one year
2,083,555
2,809,672
2,083,555
2,809,672
Payable after one year
30,173,238
34,514,335
30,173,238
34,514,335

The bank debt is secured by a debenture and unlimited intercompany composite guarantee between the group companies, supported by first legal charges over the assets of those companies.

 

The bank facilities, comprise term loans and a revolving credit facility, repayable in instalments with bullet repayments at the end of the term on 6 September 2028. Interest is charged on the term loans at between 2.25% and 2.45% above SONIA and on the revolving credit facility at 3.35% above SONIA.

 

On 2 October 2025 an interest rate cap agreed with the group's bankers over £20,000,000 of debt matured which capped the interest rate before margins at 1.5% per annum.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 32 -
23
Deferred taxation

Deferred tax assets and liabilities are offset where the group or company has a legally enforceable right to do so. The following is the analysis of the deferred tax balances (after offset) for financial reporting purposes:

Liabilities
Liabilities
2026
2025
Group
£
£
Advanced capital allowances
1,356,398
1,113,693
Revaluation of freehold properties
10,318,018
10,318,019
Revaluation of derivatives
-
28,443
11,674,416
11,460,155
Liabilities
Liabilities
2026
2025
Company
£
£
Revaluation of derivatives
-
28,443
Group
Company
2026
2026
Movements in the year:
£
£
Liability at 1 May 2025
11,460,155
28,443
Charge/(credit) to profit or loss
214,261
(28,443)
Liability at 30 April 2026
11,674,416
-
24
Retirement benefit schemes
2026
2025
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
403,987
349,306

Defined contribution pension schemes are operated for all qualifying employees. The assets of the schemes are held separately from those of the group in an independently administered fund.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 33 -
25
Share capital
Group and company
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of 1p each (2025 £1 each)
1,926
321
19
321
Ordinary B shares of 1p each
642
-
6
-
Ordinary C shares of 1p each
321
-
3
-
Ordinary D shares of 1p each
321
-
3
-
Ordinary E shares of 1p each
28,890
-
290
-
32,100
321
321
321

During the year there was a variation of rights and share class name of the shares and each Ordinary Share of £1 was split into 100 shares of 1p.

 

All share classes rank pari pasu in all respects with the existing Ordinary shares except the Ordinary A shareholder consent is required to issue new shares and for share rights to be varied.

 

26
Related party transactions
Transactions with related parties
Group

During the year the group entered into transactions with related parties as follows:

2026
2025
£
£
Company with common directors and under common control
Repairs and maintenance expenses
1,752,300
1,584,001
Property development costs
918,126
912,541
Fixtures, fittings and equipment costs
706,874
702,576
2026
2025
£
£
Company in which a director is a member of key management personnel
Interest received
-
49,993
Interest expense
216,536
-
ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
26
Related party transactions
(Continued)
- 34 -
2026
2025
£
£
Close family members of the directors
Remuneration expenses
615,580
458,458
At the year end the following balances were outstanding:
2026
2025
£
£
Amounts owed (to)/by directors (interest free and repayable on demand)
(46,101)
71,594
Amounts owed (to)/by family members of directors (interest free and
45,199
433,779
repayable on demand)
Amounts owed (to)/by companies with common directors and
70,974
525,735
under common control
Company
During the year the company entered into transactions with related parties as follows:
2026
2025
£
£
Company in which a director is a member of key management personnel
Interest received
-
49,993
Interest expense
216,536
-
2026
2025
£
£
Close family members of the directors
Remuneration expenses
324,093
386,637
At the year end the following balances were outstanding:
2026
2025
£
£
Amounts owed (to)/by directors (interest free and repayable on demand)
(45,325)
71,594
Amounts owed (to)/by family members of directors (interest free and
43,864
(13,696)
repayable on demand)
Amounts owed (to)/by company with common directors and
196,174
475,669
under common control
27
Controlling party

The controlling party was considered to be Mr J M Patel by virtue of his 100% shareholding up until 13 November 2025 when 90% of the company's shares were acquired by The JMP and DJP Discretionary Trust, in which Mr J M Patel is a non controlling trustee.

ABBEY TOTAL CARE GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2026
- 35 -
28
Cash generated from group operations
2026
2025
£
£
Profit for the year after tax
8,496,795
6,363,254
Adjustments for:
Taxation charged
2,837,173
2,095,692
Finance costs
2,259,678
2,081,929
Investment income
(253,385)
(431,835)
Amortisation and impairment of intangible assets
(877,626)
(45,953)
Depreciation and impairment of tangible fixed assets
538,859
436,570
Fair value loss on derivative
216,124
700,069
Movements in working capital:
Decrease/(increase) in debtors
677,374
(605,892)
Decrease in creditors
(202,303)
(4,309)
Cash generated from operations
13,692,689
10,589,525
29
Analysis of changes in net debt - group
1 May 2025
Cash flows
Other non-cash changes
30 April 2026
£
£
£
£
Cash at bank and in hand
7,254,144
572,669
-
7,826,813
Bank overdrafts
(681,154)
576,117
-
(105,037)
6,572,990
1,148,786
-
7,721,776
Borrowings excluding overdrafts
(36,642,853)
4,537,579
(46,482)
(32,151,756)
Obligations under finance leases
(62,461)
35,692
-
(26,769)
Loan notes
(6,000,000)
1,200,000
-
(4,800,000)
(36,132,324)
6,922,057
(46,482)
(29,256,749)
Other non-cash changes relate to the release of bank loan finance costs.
2026-04-302025-05-01falsefalseCCH SoftwareCCH Accounts Production 2026.301No description of principal activityMr J PatelMrs D PatelMrs D Patelfalse04746712bus:Consolidated2025-05-012026-04-30047467122025-05-012026-04-3004746712bus:Director12025-05-012026-04-3004746712bus:CompanySecretaryDirector12025-05-012026-04-3004746712bus:CompanySecretary12025-05-012026-04-3004746712bus:Director22025-05-012026-04-3004746712bus:RegisteredOffice2025-05-012026-04-3004746712bus:Consolidated2026-04-30047467122026-04-3004746712bus:Consolidated2024-05-012025-04-30047467122024-05-012025-04-3004746712core:Goodwillbus:Consolidated2026-04-3004746712core:Goodwillbus:Consolidated2025-04-3004746712bus:Consolidated2025-04-30047467122025-04-3004746712core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2026-04-3004746712core:FurnitureFittingsbus:Consolidated2026-04-3004746712core:MotorVehiclesbus:Consolidated2026-04-3004746712core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-04-3004746712core:FurnitureFittingsbus:Consolidated2025-04-3004746712core:MotorVehiclesbus:Consolidated2025-04-3004746712core:FurnitureFittings2026-04-3004746712core:MotorVehicles2026-04-3004746712core:FurnitureFittings2025-04-3004746712core:MotorVehicles2025-04-3004746712core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2026-04-3004746712core:CurrentFinancialInstrumentsbus:Consolidated2025-04-3004746712core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2025-04-3004746712core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2026-04-3004746712core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2025-04-3004746712core:CurrentFinancialInstrumentscore:WithinOneYear2026-04-3004746712core:CurrentFinancialInstrumentscore:WithinOneYear2025-04-3004746712core:Non-currentFinancialInstrumentscore:AfterOneYear2026-04-3004746712core:Non-currentFinancialInstrumentscore:AfterOneYear2025-04-3004746712core:ShareCapitalbus:Consolidated2026-04-3004746712core:ShareCapitalbus:Consolidated2025-04-3004746712core:RevaluationReservebus:Consolidated2026-04-3004746712core:RevaluationReservebus:Consolidated2025-04-3004746712core:OtherMiscellaneousReservebus:Consolidated2026-04-3004746712core:OtherMiscellaneousReservebus:Consolidated2025-04-3004746712core:RetainedEarningsAccumulatedLossesbus:Consolidated2026-04-3004746712core:RetainedEarningsAccumulatedLossesbus:Consolidated2025-04-3004746712core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterestsbus:Consolidated2026-04-3004746712core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterestsbus:Consolidated2025-04-3004746712core:Non-controllingInterestsbus:Consolidated2026-04-3004746712core:Non-controllingInterestsbus:Consolidated2025-04-3004746712core:ShareCapital2026-04-3004746712core:ShareCapital2025-04-3004746712core:RetainedEarningsAccumulatedLosses2026-04-3004746712core:RetainedEarningsAccumulatedLosses2025-04-3004746712core:ShareCapitalbus:Consolidated2024-04-3004746712core:SharePremiumbus:Consolidated2024-04-3004746712core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-04-3004746712core:ShareCapital2024-04-3004746712core:RetainedEarningsAccumulatedLosses2024-04-3004746712bus:Consolidated12025-05-012026-04-3004746712bus:Consolidated12024-05-012025-04-3004746712bus:Consolidated2024-04-3004746712core:Goodwill2025-05-012026-04-3004746712core:FurnitureFittings2025-05-012026-04-3004746712core:MotorVehicles2025-05-012026-04-3004746712core:Non-standardPPEClass2ComponentTotalPropertyPlantEquipment2025-05-012026-04-3004746712core:UKTaxbus:Consolidated2024-05-012025-04-3004746712bus:Consolidated22025-05-012026-04-3004746712bus:Consolidated22024-05-012025-04-3004746712core:Goodwillbus:Consolidated2025-04-3004746712core:Goodwillbus:Consolidated2025-05-012026-04-3004746712core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-04-3004746712core:FurnitureFittingsbus:Consolidated2025-04-3004746712core:MotorVehiclesbus:Consolidated2025-04-3004746712bus:Consolidated2025-04-3004746712core:FurnitureFittings2025-04-3004746712core:MotorVehicles2025-04-30047467122025-04-3004746712core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-05-012026-04-3004746712core:FurnitureFittingsbus:Consolidated2025-05-012026-04-3004746712core:MotorVehiclesbus:Consolidated2025-05-012026-04-3004746712core:Subsidiary12025-05-012026-04-3004746712core:Subsidiary22025-05-012026-04-3004746712core:Subsidiary32025-05-012026-04-3004746712core:Subsidiary42025-05-012026-04-3004746712core:Subsidiary52025-05-012026-04-3004746712core:Subsidiary62025-05-012026-04-3004746712core:Subsidiary72025-05-012026-04-3004746712core:Subsidiary82025-05-012026-04-3004746712core:Subsidiary92025-05-012026-04-3004746712core:Subsidiary102025-05-012026-04-3004746712core:Subsidiary112025-05-012026-04-3004746712core:Subsidiary122025-05-012026-04-3004746712core:Subsidiary132025-05-012026-04-3004746712core:Subsidiary142025-05-012026-04-3004746712core:Subsidiary152025-05-012026-04-3004746712core:Subsidiary162025-05-012026-04-3004746712core:Subsidiary172025-05-012026-04-3004746712core:Subsidiary112025-05-012026-04-3004746712core:Subsidiary222025-05-012026-04-3004746712core:Subsidiary332025-05-012026-04-3004746712core:Subsidiary442025-05-012026-04-3004746712core:Subsidiary552025-05-012026-04-3004746712core:Subsidiary662025-05-012026-04-3004746712core:Subsidiary772025-05-012026-04-3004746712core:Subsidiary882025-05-012026-04-3004746712core:Subsidiary992025-05-012026-04-3004746712core:Subsidiary10102025-05-012026-04-3004746712core:Subsidiary11112025-05-012026-04-3004746712core:Subsidiary12122025-05-012026-04-3004746712core:Subsidiary13132025-05-012026-04-3004746712core:Subsidiary14142025-05-012026-04-3004746712core:Subsidiary15152025-05-012026-04-3004746712core:Subsidiary16162025-05-012026-04-3004746712core:Subsidiary17172025-05-012026-04-3004746712core:CurrentFinancialInstrumentsbus:Consolidated2026-04-3004746712core:CurrentFinancialInstruments2026-04-3004746712core:CurrentFinancialInstruments2025-04-3004746712core:CurrentFinancialInstrumentsbus:Consolidated12026-04-3004746712core:CurrentFinancialInstrumentsbus:Consolidated12025-04-3004746712core:CurrentFinancialInstruments22026-04-3004746712core:CurrentFinancialInstruments22025-04-3004746712core:Non-currentFinancialInstrumentsbus:Consolidated32026-04-3004746712core:Non-currentFinancialInstrumentsbus:Consolidated32025-04-3004746712core:Non-currentFinancialInstruments42026-04-3004746712core:Non-currentFinancialInstruments42025-04-3004746712core:Non-currentFinancialInstrumentsbus:Consolidated2026-04-3004746712core:Non-currentFinancialInstrumentsbus:Consolidated2025-04-3004746712core:Non-currentFinancialInstruments2026-04-3004746712core:Non-currentFinancialInstruments2025-04-3004746712core:WithinOneYearbus:Consolidated2026-04-3004746712core:WithinOneYearbus:Consolidated2025-04-3004746712bus:PrivateLimitedCompanyLtd2025-05-012026-04-3004746712bus:FRS1022025-05-012026-04-3004746712bus:Audited2025-05-012026-04-3004746712bus:ConsolidatedGroupCompanyAccounts2025-05-012026-04-3004746712bus:FullAccounts2025-05-012026-04-30xbrli:purexbrli:sharesiso4217:GBP